MOMENTUM
Recruiting
8,000 enrolled
iCaRe2
Recruiting
999,999 enrolled
Genomic Structural Variation in Cancer Susceptibility
Active not recruiting
1,275 enrolled
OvAR-Y
Recruiting
10 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Completed
722 enrolled
SPACE2
Unknown
150 enrolled
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors
Completed
150 enrolled
PIONEER
Unknown
1,000 enrolled
PTT
Completed
33 enrolled
ADOPTR
Unknown
500 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
N1
Terminated
23 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
Unknown
2,000 enrolled
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Completed
80 enrolled
Cultured Circulating Tumor Cells in Prostate and Other Cancers
Unknown
220 enrolled
Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies
Completed
59 enrolled
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Completed
64 enrolled
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
Completed
25 enrolled
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
Completed
60 enrolled
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Terminated
8 enrolled